Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - SHORT-TERM DEBT
Short-term Debt KYMR - Kymera Therapeutics, Inc.
6.34 M
LAST VALUE
-6.11%
2 YEAR CAGR
83.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR